Investing Profile

Jakob Loven

InvestorVC
Managing Partner at Nextech Invest
nextechinvest.com/team/jakob-...Zurich, Switzerland
Photo of Jakob Loven, Managing Partner at Nextech Invest
Your Intro Paths to Jakob Loven

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Jakob Loven on

cb
Current Investing Position
Nextech Invest Managing Partner
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
11

Jakob Loven is on these Sector & Stage Rankings

Jakob Loven's Investments On Record (8)

CompanyStageDateRound SizeTotal Raised
Boundless Bio
Series CMay 2023$100M
Series BApr 2021$110M
$250M
Co-investors: Jonathan Lim (SignalFire), Zach Scheiner (RA Capital), Jonathan Lim (ARCH Venture Partners)
Flare Therapeutics
Series BMar 2023$120M
$210M
Co-investors: Abbie Celniker (Third Rock Ventures)
Hexagon Bio
Series BOct 2022$77M
Series UnknownSep 2021$61M
$190M
Co-investors: Alex Kolicich (8VC), Millie Ray (The Column Group), David Goeddel (The Column Group), Dusan Perovic (Two Sigma Ventures)
IconOVir Bio
Series AJan 2021$77M
$77M
Co-investors: Helen Kim (Vida Ventures)
Kronos Bio
Private EquityAug 2020$160M
Series AJul 2019$110M
$320M
Co-investors: Martin Alexander Gershon (Endeavor Venture Funds), Arie Belldegrun (Vida Ventures)
Vividion Therapeutics
Series BApr 2019$82M
$270M
Co-investors: Tom Woiwode (Versant Ventures), Kristina Burow (ARCH Venture Partners)
Arrakis Therapeutics
Series BApr 2019$75M
$110M
Co-investors: Colleen Cuffaro (Canaan Partners), Richard Gaster (venBio)
Arvinas
Series CApr 2018$55M
$140M
Co-investors: Kush Parmar (5am Ventures), Tim Shannon (Canaan Partners), Colleen Cuffaro (Canaan Partners), Stephen Squinto (OrbiMed), Liam Ratcliffe (Access Biotechnology), Andrew Levin (RA Capital), Martin Alexander Gershon (Endeavor Venture Funds), Daniel Wagner (Connecticut Innovations)

Jakob Loven's Experience

Board Observer IDRx2022 - Present
Board Member Hexagon Bio2021 - Present
Board Member Flare Therapeutics2021 - Present
Board Member Boundless Bio2021 - Present
Board Member IconOVir Bio2021 - Present
Advisory Board Breakthrough Properties2020 - Present
Board Member Arrakis Therapeutics2019 - Present
Board Member A2 Biotherapeutics, Inc.2018 - Present
Managing Partner Nextech Invest Ltd.2017 - Present
Board Observer Kinnate Biopharma, Inc.2019 - 2021
Board Member Vividion Therapeutics. Inc.2019 - 2021
Board Member Kronos Bio, Inc.2019 - 2021
Board Member Arvinas2018 - 2020
Board Observer Turning Point Therapeutics2018 - 2019
Board Observer Autolus Ltd.2017 - 2018
Co-Founder Relay Therapeutics2016 - 2017
Senior Investment Proffesional Third Rock Ventures2015 - 2017
Senior Adviser, SACC Life Science Acclerator Swedish American Chamber of Commerce - New England2013 - 2016
Co-Founder Syros Pharmaceuticals2013 - 2015
Postdoctoral Fellow Whitehead Institute2010 - 2013
PhD in Medical Sciences Karolinska Institutet2005 - 2010
Research Scientist AstraZeneca2002 - 2005
Conscript Officer and Boat Commander in the Swedish Royal Navy Special Forces Swedish Armed Forces1997 - 1999

Jakob Loven's Education

Karolinska Institutet Doctor of Philosophy (Ph.D.) Medical Sciences
Anglia Ruskin University Bachelor's degree Biomedical Sciences
Sigtunaskolan Humanistiska Läroverket (SSHL) International Baccalaureate Natural Sciences